Cancer Research AACR Legacy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goepfert, T. M.
Right arrow Articles by Brinkley, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goepfert, T. M.
Right arrow Articles by Brinkley, W. R.
[Cancer Research 62, 4115-4122, July 15, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Centrosome Amplification and Overexpression of Aurora A Are Early Events in Rat Mammary Carcinogenesis1

Thea M. Goepfert2, Yetunde E. Adigun, Ling Zhong, Jason Gay, Daniel Medina and William R. Brinkley

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030

The cells of many solid tumors have been found to contain supernumerary centrosomes, a condition known as centrosome amplification. Centrosome amplification, accompanied by the overexpression of an associated kinase, Aurora A (AurA), has been implicated in mechanisms leading to mitotic spindle aberrations, aneuploidy, and genomic instability. Using a well-established rat mammary model favorable for experimental carcinogenesis, we analyzed centrosome amplification as a cellular marker for early stages of transformation and its regulation by the kinase ratAurA. Parity or treatment with estrogen and progesterone conferred resistance to tumorigenesis, as well as to overexpression of ratAurA and to centrosome amplification. ratAurA, cloned from a rat mammary gland cDNA library, is a bona fide Ser/Thr kinase, and sequence comparison demonstrated high homology to members of the entire AurA kinase family. Using immunocytochemical localization with confocal microscopy, we found ratAurA to be localized at the centrosome in normal and neoplastic tissues of the rat mammary gland. Normal ductal epithelium and stromal cells displayed an expected complement of one to two centrosomes/cell, whereas comparable cells in methylnitrosourea-treated animals displayed significantly elevated centrosome numbers. In tumors, 46% of cells showed more than two centrosomes/cell, and ratAurA expression levels coincided with higher centrosome numbers. Both centrosome numbers and ratAurA expression were permanently elevated. Centrosome amplification was found to occur at a very early, premalignant stage prior to detectable lesions after treatment with methylnitrosourea, a condition that was not detected in mammary glands of rats made refractory to the carcinogen via pregnancy or estrogen and progesterone treatment. Our results indicate that hormones influence kinase expression, and progesterone had the major effect on ratAurA expression levels. Cumulatively, these results suggest that ratAurA overexpression and centrosome amplification were linked to tumor development and progression and may serve as early markers in tumorigenesis.




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. C. Torchia, Y. Chen, H. Sheng, H. Katayama, J. Fitzpatrick, W. R. Brinkley, C. Caulin, S. Sen, and D. R. Roop
A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors
Cancer Res., September 15, 2009; 69(18): 7207 - 7215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-S. Jang, J.-W. Sul, B.-J. Choi, S.-J. Lee, J.-H. Suh, N.-S. Kim, W. H. Kim, D.-S. Lim, C.-W. Lee, and E. Kim
Negative Feedback Regulation of Aurora-A via Phosphorylation of Fas-associated Factor-1
J. Biol. Chem., November 21, 2008; 283(47): 32344 - 32351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. A. Dar, A. Belkhiri, J. Ecsedy, A. Zaika, and W. El-Rifai
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
Cancer Res., November 1, 2008; 68(21): 8998 - 9004.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H. H. Lee, Y. Zhu, K. M Govindasamy, and G. Gopalan
Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells
Endocr. Relat. Cancer, September 1, 2008; 15(3): 765 - 775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Man, J. Rosa, Y. L. Yip, A. L.-M. Cheung, Y. L. Kwong, S. J. Doxsey, and S. W. Tsao
Id1 Overexpression Induces Tetraploidization and Multiple Abnormal Mitotic Phenotypes by Modulating Aurora A
Mol. Biol. Cell, June 1, 2008; 19(6): 2389 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. I. van de Wetering and C. M. Knudson
Chromosomal Instability and Supernumerary Centrosomes Represent Precursor Defects in a Mouse Model of T-Cell Lymphoma
Cancer Res., September 1, 2007; 67(17): 8081 - 8088.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. N. Landen Jr., Y. G. Lin, A. Immaneni, M. T. Deavers, W. M. Merritt, W. A. Spannuth, D. C. Bodurka, D. M. Gershenson, W. R. Brinkley, and A. K. Sood
Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients
Clin. Cancer Res., July 15, 2007; 13(14): 4098 - 4104.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. J. LeRoy, J. J. Hunter, K. M. Hoar, K. E. Burke, V. Shinde, J. Ruan, D. Bowman, K. Galvin, and J. A. Ecsedy
Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558 by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity
Cancer Res., June 1, 2007; 67(11): 5362 - 5370.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
V. Horn, J. Thelu, A. Garcia, C. Albiges-Rizo, M. R. Block, and J. Viallet
Functional Interaction of Aurora-A and PP2A during Mitosis
Mol. Biol. Cell, April 1, 2007; 18(4): 1233 - 1241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. D. Slack, Z. Chen, A. D. Ludwig, J. Hicks, and J. M. Shohet
MYCN-Directed Centrosome Amplification Requires MDM2-Mediated Suppression of p53 Activity in Neuroblastoma Cells
Cancer Res., March 15, 2007; 67(6): 2448 - 2455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Briassouli, F. Chan, K. Savage, J. S. Reis-Filho, and S. Linardopoulos
Aurora-A Regulation of Nuclear Factor-{kappa}B Signaling by Phosphorylation of I{kappa}B{alpha}
Cancer Res., February 15, 2007; 67(4): 1689 - 1695.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Fu, M. Bian, Q. Jiang, and C. Zhang
Roles of Aurora Kinases in Mitosis and Tumorigenesis
Mol. Cancer Res., January 1, 2007; 5(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Yamamoto, H. Matsuyama, S. Kawauchi, T. Furuya, X. P. Liu, K. Ikemoto, A. Oga, K. Naito, and K. Sasaki
Biological characteristics in bladder cancer depend on the type of genetic instability.
Clin. Cancer Res., May 1, 2006; 12(9): 2752 - 2758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Suizu, A. Ryo, G. Wulf, J. Lim, and K. P. Lu
Pin1 Regulates Centrosome Duplication, and Its Overexpression Induces Centrosome Amplification, Chromosome Instability, and Oncogenesis
Mol. Cell. Biol., February 15, 2006; 26(4): 1463 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Fukuda, Y. Mishina, M. P. Walker, and R. P. DiAugustine
Conditional Transgenic System for Mouse Aurora A Kinase: Degradation by the Ubiquitin Proteasome Pathway Controls the Level of the Transgenic Protein
Mol. Cell. Biol., June 15, 2005; 25(12): 5270 - 5281.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Li, S. J. Weroha, W. L. Lingle, D. Papa, J. L. Salisbury, and S. A. Li
Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats
PNAS, December 28, 2004; 101(52): 18123 - 18128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Liu, S. Kaneko, L. Yang, R. I. Feldman, S. V. Nicosia, J. Chen, and J. Q. Cheng
Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215
J. Biol. Chem., December 10, 2004; 279(50): 52175 - 52182.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Sun, X. Miao, J. Wang, W. Tan, Y. Zhou, C. Yu, and D. Lin
Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma
Carcinogenesis, November 1, 2004; 25(11): 2225 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Yamamoto, H. Matsuyama, T. Furuya, A. Oga, S. Yoshihiro, M. Okuda, S. Kawauchi, K. Sasaki, and K. Naito
Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder Cancer
Clin. Cancer Res., October 1, 2004; 10(19): 6449 - 6455.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
U. Schlecht, P. Demougin, R. Koch, L. Hermida, C. Wiederkehr, P. Descombes, C. Pineau, B. Jegou, and M. Primig
Expression Profiling of Mammalian Male Meiosis and Gametogenesis Identifies Novel Candidate Genes for Roles in the Regulation of Fertility
Mol. Biol. Cell, March 1, 2004; 15(3): 1031 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yang, C. C. Ou, R. I. Feldman, S. V. Nicosia, P. A. Kruk, and J. Q. Cheng
Aurora-A Kinase Regulates Telomerase Activity through c-Myc in Human Ovarian and Breast Epithelial Cells
Cancer Res., January 15, 2004; 64(2): 463 - 467.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Hoque, J. Carter, W. Xia, M.-C. Hung, A. A. Sahin, S. Sen, and S. M. Lippman
Loss of Aurora A/STK15/BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1518 - 1522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kazerounian and S. Aho
Characterization of Periphilin, a Widespread, Highly Insoluble Nuclear Protein and Potential Constituent of the Keratinocyte Cornified Envelope
J. Biol. Chem., September 19, 2003; 278(38): 36707 - 36717.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. L. Warner, D. J. Bearss, H. Han, and D. D. Von Hoff
Targeting Aurora-2 Kinase in Cancer
Mol. Cancer Ther., June 1, 2003; 2(6): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. Dutertre and C. Prigent
Aurora-A Overexpression Leads to Override of the Microtubule-Kinetochore Attachment Checkpoint
Mol. Interv., May 1, 2003; 3(3): 127 - 130.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. M. Gritsko, D. Coppola, J. E. Paciga, L. Yang, M. Sun, S. A. Shelley, J. V. Fiorica, S. V. Nicosia, and J. Q. Cheng
Activation and Overexpression of Centrosome Kinase BTAK/Aurora-A in Human Ovarian Cancer
Clin. Cancer Res., April 1, 2003; 9(4): 1420 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. A. Pihan, J. Wallace, Y. Zhou, and S. J. Doxsey
Centrosome Abnormalities and Chromosome Instability Occur Together in Pre-invasive Carcinomas
Cancer Res., March 15, 2003; 63(6): 1398 - 1404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.